Insider Transactions in Q1 2021 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 12
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.07%
|
$1,999,326
$181.29 P/Share
|
|
Feb 12
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$925,000
$185.0 P/Share
|
|
Feb 11
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,780,000
$178.29 P/Share
|
|
Feb 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,638,000
$182.74 P/Share
|
|
Feb 08
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$880,000
$176.98 P/Share
|
|
Feb 08
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 08
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,670
-31.28%
|
$667,940
$182.71 P/Share
|
|
Feb 08
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,670
+50.0%
|
$44,040
$12.21 P/Share
|
|
Feb 05
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.0%
|
$1,922,004
$174.12 P/Share
|
|
Feb 04
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,660,000
$166.42 P/Share
|
|
Feb 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,404,000
$156.51 P/Share
|
|
Feb 03
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.61%
|
$1,560,000
$156.51 P/Share
|
|
Feb 03
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 02
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.61%
|
$1,580,000
$158.4 P/Share
|
|
Feb 02
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-29.26%
|
$815,000
$163.67 P/Share
|
|
Feb 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 01
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$860,000
$172.99 P/Share
|
|
Feb 01
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 29
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.41%
|
$1,933,050
$175.12 P/Share
|
|
Jan 28
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,540,000
$154.11 P/Share
|
|
Jan 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jan 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,359,000
$151.27 P/Share
|
|
Jan 25
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$690,000
$138.77 P/Share
|
|
Jan 25
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 25
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.15%
|
$2,840,000
$142.97 P/Share
|
|
Jan 25
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.6%
|
$0
$0.99 P/Share
|
|
Jan 25
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-35.95%
|
$710,000
$142.51 P/Share
|
|
Jan 25
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$1,365,000
$273.01 P/Share
|
|
Jan 24
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
|
Jan 22
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.9%
|
$1,458,072
$132.13 P/Share
|
|
Jan 21
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,250,000
$125.28 P/Share
|
|
Jan 20
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jan 20
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,116,000
$124.51 P/Share
|
|
Jan 19
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$605,000
$121.88 P/Share
|
|
Jan 19
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-46.93%
|
$615,000
$123.63 P/Share
|
|
Jan 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 15
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.85%
|
$1,435,980
$130.14 P/Share
|
|
Jan 14
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,220,000
$122.83 P/Share
|
|
Jan 13
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.08%
|
$1,230,000
$123.7 P/Share
|
|
Jan 13
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.91%
|
$1,845,000
$123.7 P/Share
|
|
Jan 13
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.6%
|
$0
$0.99 P/Share
|
|
Jan 12
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.3%
|
$585,000
$117.5 P/Share
|
|
Jan 11
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-42.03%
|
$580,000
$116.56 P/Share
|
|
Jan 11
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|